Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). - Wikidata - wikimedia - TriplyDB

Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).

Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).

http://www.wikidata.org/entity/Q43487270

about

Outcome assessment in Takayasu arteritis Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12 Recent advances in Takayasu's arteritis The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey.Clinical study of children with Takayasu arteritis: a retrospective study from a single center in China.Role of inflammatory markers in Takayasu arteritis disease monitoring.Variations in the clinical practice of physicians managing Takayasu arteritis: a nationwide survey Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis.Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom.High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins Vessel Wall Inflammation of Takayasu Arteritis Detected by Contrast-Enhanced Magnetic Resonance Imaging: Association with Disease Distribution and Activity.Increased Circulating Th17 Cells, Serum IL-17A, and IL-23 in Takayasu Arteritis Takayasu arteritis: criteria for surgical intervention should not be ignored.Serum Cytokine Profile in Asian Indian Patients with Takayasu Arteritis and its Association with Disease Activity.Optimizing the outcome of vascular intervention for Takayasu arteritis.Recent advances in Takayasu arteritis.Clinical diagnosis and management of large vessel vasculitis: Takayasu arteritis.Childhood-onset Takayasu arteritis: an update.Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu's arteritis.18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis.Leflunomide in Takayasu arteritis - A long term observational study.Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience.Pediatric-onset Takayasu's arteritis: clinical features and short-term outcome.Development of a colour Doppler ultrasound scoring system in patients of Takayasu's arteritis and its correlation with clinical activity score (ITAS 2010).Childhood Takayasu arteritis: disease course and response to therapy.18F-FDG-PET/CT: an accurate method to assess the activity of Takayasu's arteritis.Management of Takayasu arteritis.Clinical interventions for Takayasu arteritis: A systematic review.Takayasu arteritis in paediatrics.Unmet Needs in the Pathogenesis and Treatment of Vasculitides.Issues in trial design for ANCA-associated and large-vessel vasculitis.Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis.Novel Angiographic Scores for evaluation of Large Vessel Vasculitis Takayasu Arteritis Takayasu's disease effects on the kidneys: current perspectives Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study

P2860

Q26782601-AA4592AA-22C3-4AE9-A355-54C388EA30B1 Q28081372-412E91AC-B8F0-4C2E-AA7B-60496E05B2C5 Q28083670-5419D937-133D-4B6A-B661-BB18D2A22053 Q30251845-2F5CBB71-2938-4F01-B5F1-DBB0E0B9F8F2 Q33568763-8074A8BB-682E-45F7-B99A-44F22ADB6FF7 Q33575976-1E8509D5-EC75-4CC4-82BB-F4117B02A581 Q33662694-307207A0-86AC-494B-808C-54EED9F75C88 Q33813735-A29E2A2F-265F-452A-BEF8-8CC337A62223 Q33841384-C7D2B10F-5717-4296-BE8E-4BA29F515F16 Q35354592-5D6739B3-661F-4B5A-BE0F-366201B8BBCD Q35782029-82A4FB19-648A-43F7-83E9-6E5AE38AF85F Q35882755-24C0C7B9-AC35-4D2C-A4B4-B224D02B80F5 Q36731105-B0260D22-F950-4322-B478-E5C779455653 Q37108722-B1ADE95C-1613-4BB6-8BFE-F8CD344B45A4 Q37721330-97894B87-A2B9-4A3E-B811-49D6E33444F7 Q38174508-E85BD4ED-152B-4D79-83E8-1907CF6F0B1E Q38189191-A9D6E98F-4760-4918-8AFD-22B187ABD787 Q38217342-397573C2-D6E8-4C01-874C-3B521B4A3B8A Q38638940-36D72F6B-10DD-4FF6-AB77-48982FA7D251 Q38652865-94B89C0B-AD2C-425F-A586-403194913618 Q38970688-A4AB800D-6D4C-4BBF-8155-7EB0FC9AD854 Q39961951-9A1A0706-9942-4126-A1D4-41AC7A660988 Q40459457-40A0F6B3-B4FE-4161-BAE6-60D442AFF58B Q41027560-A7D9AAD0-0E9F-4C68-BCC5-B81EB881A383 Q44128341-DE8E2DE0-E4D4-494A-B089-966C6DCFFC49 Q47165426-92FBBDB3-19F7-4705-A6A3-B7A66EC0391F Q47233590-D8CAAC66-5634-4DE9-840D-3393843CB4C9 Q47730853-80337550-6515-43DB-A945-AB6E6BD387DB Q47998169-F1533837-F78D-498F-9C14-100BC18D4A7A Q48514082-FCF89C2A-C9AC-454C-960E-6A2516C65782 Q48592090-7D0F3493-FD12-45E7-A9AA-8EF66B5398DD Q48937679-127FFDB5-0304-47B8-BB5F-6DAE2931864A Q52718727-FEE031DF-2286-474F-9B33-6D67A363E8B2 Q58107256-98B54676-6812-4AD2-9ED5-2A8D088FF6EE Q58552082-828CAB82-ACBD-428B-A77F-87981B01F7F9 Q58777758-0DB43844-12F4-4A53-A9D9-E602230876DA Q59130566-1775FC2C-6F9F-4BCB-97D7-796BDD9D1C48

P2860

Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).

http://www.wikidata.org/entity/Q43487270

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Development and initial valida ...... cal Activity Score (ITAS2010).

@en

Development and initial validation of the Indian Takayasu Clinical Activity Score

@nl

type

label

Development and initial valida ...... cal Activity Score (ITAS2010).

@en

Development and initial validation of the Indian Takayasu Clinical Activity Score

@nl

prefLabel

Development and initial valida ...... cal Activity Score (ITAS2010).

@en

Development and initial validation of the Indian Takayasu Clinical Activity Score

@nl

P1433

Q43487270-55218F6D-6368-4BFD-A1BB-AF2311EFC484

P1476

Q43487270-743C611E-3825-4AB6-80EF-7D66077F4741

P2093

Q43487270-03693FF9-DE0F-4DBE-B851-FAB139B952A9

Q43487270-10501A9E-B9FD-439D-BF87-BEA99C926879

Q43487270-50D15CDE-AADA-427E-B9DC-CB8EBDCFBD4A

Q43487270-83709D91-AB9F-4B75-9D25-1865ABD80922

Q43487270-86120FCA-D1C9-4857-BFE3-805FAF7B437D

Q43487270-982AFEF5-3AF0-44BB-A70A-773640156F82

Q43487270-BDCAB1AB-DA0A-4C94-8E88-8E8C6DD97BCD

Q43487270-D4AC9BE9-B4D8-44B1-BE48-5D650A8219DF

Q43487270-FBD11485-7183-456E-B1E1-776649638C3F

P2860

Q43487270-020CD551-D1CC-44F3-B375-C24FB4792708

Q43487270-075E893A-9D7E-40B3-A045-3BD9D80C23F5

Q43487270-1559648B-B6CC-4995-81A7-5BA3759D3A50

Q43487270-17976F2E-86DE-4097-BB09-5AB36A29FC20

Q43487270-4075676D-4BCA-492D-ADF7-9EC2ABCF5550

Q43487270-70E1A835-27EC-48DD-9776-47073CA06279

Q43487270-74BE07C4-BDE8-43EA-BE10-2E58300C8E73

Q43487270-7DD968E7-626B-450A-9673-4115BD5D5F03

Q43487270-AE2695AE-F6C7-41DC-B034-4D225691818F

Q43487270-B1916CEE-D7CE-4E72-B461-020B6FE48BF7

P304

Q43487270-D1C7FBEB-E299-449C-BE78-9FE9AB621F27

P31

Q43487270-47E2DB1D-CA1B-49E3-AC0F-DC6846971825

P356

Q43487270-D7FE7BF4-F2DC-4588-B23E-91CD496B62ED

P433

Q43487270-D22C761A-6A16-4FC9-AA6B-E1B8BDA75A37

P478

Q43487270-8232310F-CA06-43B9-B0E2-4CA73B25B73F

P50

Q43487270-3E759A7E-866B-4D5C-887C-8C20541663C4

P577

Q43487270-30DC5A0F-0DE7-40BC-9D0D-B97C4C0E2134

P5875

Q43487270-56A4A850-CAD4-416C-958B-6477CA275720

P698

Q43487270-54CDFFFB-8458-4873-B7CB-21B2879DF5AF

P356

P1433

P1476

Development and initial valida ...... ical Activity Score (ITAS2010)

@en

P2093

Alakendu Ghosh

http://www.w3.org/2001/XMLSchema#string

Debashish Danda

http://www.w3.org/2001/XMLSchema#string

Indian Rheumatology Vasculitis (IRAVAS) group

http://www.w3.org/2001/XMLSchema#string

Kurugodu M Mahendranath

http://www.w3.org/2001/XMLSchema#string

Lakshmanan Jeyaseelan

http://www.w3.org/2001/XMLSchema#string

Paul A Bacon

http://www.w3.org/2001/XMLSchema#string

Rajiva Gupta

http://www.w3.org/2001/XMLSchema#string

Ramnath Misra

http://www.w3.org/2001/XMLSchema#string

Sivakumar M Rajappa

http://www.w3.org/2001/XMLSchema#string

P2860

Magnetic resonance imaging in the diagnosis and follow up of Takayasu's arteritis in children.

Diagnostic imaging in Takayasu arteritis.

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update.

Takayasu arteritis--advances in diagnosis and management.

Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI.

Takayasu arteritis.

Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study.

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.

P304

1795-1801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KET128

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262043124

http://www.w3.org/2001/XMLSchema#string

P698

23594468

http://www.w3.org/2001/XMLSchema#string